Myovant Sciences Ltd. Increase (Decrease) in Accounts Receivable
Myovant Sciences Ltd. reported Increase (Decrease) in Accounts Receivable of $17.73 million for the 9-month period ending 2022-12-31, per its 10-Q filed 2023-01-26.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2023-01-26
- Myovant Sciences Ltd. increase (decrease) in accounts receivable for the quarter ending 2022-12-31 was $7.26M, a 61.02% increase year-over-year.
- Myovant Sciences Ltd. increase (decrease) in accounts receivable for the quarter ending 2022-09-30 was $4.11M, a 8.43% increase year-over-year.
- Myovant Sciences Ltd. increase (decrease) in accounts receivable for the quarter ending 2022-06-30 was $6.35M, a 9.75% decline year-over-year.
- Myovant Sciences Ltd. increase (decrease) in accounts receivable for the quarter ending 2022-03-31 was $4.39M, a 22.86% increase year-over-year.
- Myovant Sciences Ltd. increase (decrease) in accounts receivable for fiscal 2022 was $19.73M, a 452.55% increase from fiscal 2021.
- Myovant Sciences Ltd. increase (decrease) in accounts receivable for fiscal 2021 was $3.57M.
- Myovant Sciences Ltd. increase (decrease) in accounts receivable for fiscal 2020 was $0.00.
- Myovant Sciences Ltd. increase (decrease) in accounts receivable for fiscal 2019 was $0.00.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|
| 2022-12-31 | $7.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-01-26 | $11.37M derived: sum of 2 quarters · filed 2023-01-26 | $17.73M 10-Q · filed 2023-01-26 | $22.11M derived: sum of 4 quarters · filed 2023-01-26 |
| 2022-09-30 | $4.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-10-26 | $10.47M 10-Q · filed 2022-10-26 | $14.85M derived: sum of 3 quarters · filed 2022-10-26 | $19.36M derived: sum of 4 quarters · filed 2023-01-26 |
| 2022-06-30 | $6.35M 10-Q · filed 2022-07-27 | $10.74M derived: sum of 2 quarters · filed 2022-07-27 | $15.25M derived: sum of 3 quarters · filed 2023-01-26 | $19.04M derived: sum of 4 quarters · filed 2023-01-26 |
| 2022-03-31 | $4.39M derived: 10-K 12 month − 10-Q 9 month · filed 2022-05-11 | $8.89M derived: sum of 2 quarters · filed 2023-01-26 | $12.69M derived: sum of 3 quarters · filed 2023-01-26 | $19.73M 10-K · filed 2022-05-11 |
| 2021-12-31 | $4.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-01-26 | $8.30M derived: sum of 2 quarters · filed 2023-01-26 | $15.34M 10-Q · filed 2023-01-26 | $18.91M derived: sum of 4 quarters · filed 2023-01-26 |
| 2021-09-30 | $3.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-10-26 | $10.83M 10-Q · filed 2022-10-26 | $14.40M derived: sum of 3 quarters · filed 2022-10-26 | $14.40M derived: sum of 4 quarters · filed 2022-10-26 |
| 2021-06-30 | $7.04M 10-Q · filed 2022-07-27 | $10.61M derived: sum of 2 quarters · filed 2022-07-27 | $10.61M derived: sum of 3 quarters · filed 2022-07-27 | $10.61M derived: sum of 4 quarters · filed 2022-07-27 |
| 2021-03-31 | $3.57M derived: 10-K 12 month − 10-Q 9 month · filed 2022-05-11 | $3.57M derived: sum of 2 quarters · filed 2022-05-11 | $3.57M derived: sum of 3 quarters · filed 2022-05-11 | $3.57M 10-K · filed 2022-05-11 |
| 2020-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-01-26 | $0.00 derived: sum of 2 quarters · filed 2022-01-26 | $0.00 10-Q · filed 2022-01-26 | |
| 2020-09-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-10-26 | $0.00 10-Q · filed 2021-10-26 | ||
| 2020-06-30 | $0.00 10-Q · filed 2021-07-28 | |||
| 2020-03-31 | $0.00 10-K · filed 2022-05-11 | |||
| 2019-03-31 | $0.00 10-K · filed 2021-05-11 |